1IA
IART icon

1834 Investment Advisors’s Integra LifeSciences IART Stock Holding History

1834 Investment Advisors’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-41
Closed -$2K – 437
2020
Q2 		$2K Buy
+41
New +$2.02K ﹤0.01% 424

Other funds holding IART

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EVM
Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

1834 Investment Advisors's IART Position: Q3 2020 in Review

1834 Investment Advisors sold out of Integra LifeSciences (IART) in Q3 2020, closing a stake of 41 shares — an estimated $2K sold.

1834 Investment Advisors first reported a position in IART in Q2 2020 and held it in 1 quarter. The position peaked at $2K in Q2 2020. 237 funds tracked by Wall St. Rank hold IART as of Q3 2020.

  • 1834 Investment Advisors reported no remaining Integra LifeSciences position as of Q3 2020 after selling out during the quarter.
  • 1834 Investment Advisors sold 41 Integra LifeSciences shares in Q3 2020, an estimated $2K.
  • 1834 Investment Advisors first reported a position in Integra LifeSciences in Q2 2020 and held it in 1 quarter.
  • 1834 Investment Advisors's Integra LifeSciences position peaked at $2K in Q2 2020.
  • 237 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2020.

Based on 1834 Investment Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.